A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice, says new research from scientists at Weill Cornell Medicine.
A Weill Cornell Medicine study published Dec. 7 represents the first time scientists have captured the restoration of communication of a minimally conscious patient by measuring aspects of brain structure and function.
Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.
Tanzania recently became a partner of the Cornell-affiliated Next Generation Cassava Breeding project, joining Nigeria and Uganda in the effort to improve cassava breeding in Africa.
